HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an overview of the Company’s business strategy and commercial and development-stage programs will be given at the 2012 Southern California Investor Conference being held at the Marriott Hotel in Newport Beach, CA. The Spectrum Pharmaceuticals presentation will be at 9:00am Pacific Time on Thursday, August 30, 2012.
